Search Results 151-160 of 14768 for alt
Although Rimegepant is rarely associated with abnormal circulating liver enzymes, we shall exclude patients with baseline AST or ALT equal to or greater than ...
ANC ≥ 1500/mcL, AST and ALT < 2 x upper limit of normal (ULN), total bilirubin ≤ 3 mg/dL, creatinine clearance ≥ 50 mL/min, platelet count ≥ 100,000/mcL ...
Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...
Mayo Clinic healthcare professionals perform research to develop new treatments for atherosclerosis. They also study ways to reduce the risk of heart attacks ...
If attributed to tumor involvement, AST and ALT <5×ULN. Subjects a history of hepatitis (Exclusion Criterion No. 11) must have ALT within the normal range.
Mayo Clinic cardiologists, cardiovascular surgeons and others perform clinical research to develop new treatments and approaches to reduce the risk of heart ...
... ALT < 5 times ULN for age). Shortening fraction of >= 27%; or; Ejection fraction of >= 50%. Patients must have a normal blood sugar level for age to ...
The Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This ...
Serum AST and ALT/SGPT ≤ 3.0 x ULN; Total bilirubin ≤ 1.5 x ULN; Estimated creatinine clearance ≥ 30 mL/min. Exclusion Criteria. Any prior systemic treatment ...
perioperative statin group. Exclusion Criteria: pregnancy; lactating females; oral or parenteral corticosteroid use in the past 30 days; elevation of AST or ALT ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.